StockData
CLBNYSEOil & Gas Field Services, NECFiscal year ends December 31

Core Laboratories Inc. /DE/

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026
$10.15+0.15 (+1.50%)

Close on Oct 19, 2026

Market cap
$475.81M
P/E (TTM)
19.5
Dividend yield
0.39%

About Core Laboratories

Oil & Gas Field Services, NEC, SIC 1389

Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry. The company operates through two segments: Reservoir Description and Production Enhancement. Its Reservoir Description segment characterizes petroleum reservoir rock and fluid samples to help clients evaluate reservoir performance and increase recovery, while also supporting energy transition projects such as carbon capture and geothermal initiatives. The Production Enhancement segment offers perforating products, diagnostic services, and well completion solutions to optimize well stimulation and field development. The company serves major, national, and independent oil companies, as well as universities and research facilities.

The company operates facilities and offices across more than 50 countries, with non-U.S. operations spanning regions including Europe, Africa, the Middle East, Asia Pacific, Canada, Latin America, and the Former Soviet Union. Its global network consists of more than 70 offices and approximately 3,300 employees, with manufacturing primarily conducted in four facilities across the United States and Canada. Core Laboratories Inc. is incorporated in Delaware, though its specific headquarters location is not stated in the text.

Summary of the business section of Core Laboratories's latest annual report, written by StockData.

Company profile

Company

Legal name
Core Laboratories Inc. /DE/
Founded
1936
Headquarters
Houston, TX
Address
6316 Windfern Road 77040
Phone
(713) 328-2673
Employees
3,300, Dec 31, 2025
Industry
Oil & Gas Field Services, NEC
Incorporated in
Delaware
Fiscal year ends
December 31
Auditor
KPMG LLP, Houston, TX

Stock & identifiers

Ticker
CLB
Exchange
NYSE
Shares outstanding
46M, Jul 24, 2026
Public float
$498.91M, Jun 30, 2025
Filer category
Large accelerated filer
Stock splits
2-for-1, Jul 9, 2010; 2-for-1, Dec 22, 1997
SEC CIK
1958086
CUSIP
21867A105
ISIN
US21867A1051
LEI
984500040P5J07V43135
EIN
00-0000000

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Lawrence BrunoChairman and CEO, Director262,438
Sow Hang TeoCAO & Treasurer8,625
Mark Damian TattoliSVP, Gen Counsel & Secretary29,478
Gwendolyn GreshamSVP33,226
Christopher Scott HillSVP & CFO110,261
Katherine MurrayDirector29,290
Curt AnastasioDirector23,805
Robert F. MartinovichDirector8,069
Martha Z. CarnesDirector54,397
Harvey Robert KlingensmithDirector50,031
Kwaku TemengDirector33,597
Michael StraughenDirector24,552

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2025
Mr. Bruno
$4.98M$3.32M$1.38M$61$181
FY2024
First Ceo
$7.93M$6.50M$1.64M$47$101
FY2024
Mr. Bruno
$5.72M$6.50M$1.64M$47$101
FY2024
Second Ceo
$0$0$1.64M$47$101
FY2023
First Ceo
$7.99M$3.87M$1.94M$48$113
FY2023
Mr. Bruno
$7.99M$3.87M$1.94M$48$113

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Employees

Headcount reported in annual reports

Corporate history

Events identified from SEC filings

DateEventDetails
Mar 3, 2026Late filingNotification of late filing
Feb 28, 2023Name changeName changed from Core Laboratories Luxembourg S.A. to Core Laboratories Inc. /DE/
Jan 17, 2023MergerRegistration of securities for a merger or exchange offer (S-4)